The development of TNF alpha blocker biologics for the treatment of psoriasis, psoriatic arthritis, RA, Crohn's disease, and ankylosing spondylitis is a major breakthrough in the treatment for autoimmune diseases. Here, TNF is linked to psoriatic arthritis.